Bio-Techne
TECH
#2238
Rank
S$11.24 B
Marketcap
S$71.81
Share price
-0.25%
Change (1 day)
8.73%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2026 (TTM): S$0.91

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is S$0.91. In 2025 the company made an earnings per share (EPS) of S$0.67 a decrease over its 2024 EPS that were of S$1.28.

EPS history for Bio-Techne from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$0.9137.25%
2025S$0.67-48%
2024S$1.28-29.58%
2023S$1.82-14.97%
2022S$2.1424.16%
2021S$1.7217.98%
2020S$1.46-10.94%
2019S$1.64101.57%
2018S$0.81-16.99%
2017S$0.9845.02%
2016S$0.68-20.97%
2015S$0.86-14.97%
2014S$1.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
S$23.35 2,466.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
S$7.00 669.01%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
S$10.50 1,053.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
S$6.65 630.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
S$2.64 190.15%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
S-$0.27-129.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
S$7.83 760.56%๐Ÿ‡บ๐Ÿ‡ธ USA